ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: RFP Offers Patent Rights Instead Of Profit; ACS, NCI Plan More Joint Projects; BC Report Sept. 30

September 20, 1974

House Members Who Voted for Veto

January 3, 1986

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981